MEDANTA NSE filing

Global Health Limited Schedules 22nd AGM for September 16, 2026

The RealCase readLow impact Neutral

Global Health Limited (Medanta) will hold its 22nd AGM on September 16, 2026, via VC/OAVM. Annual report and AGM notice for FY25-26 dispatched on August 21, 2026. Remote e-voting available from September 12-15, 2026. Cut-off date for voting rights is September 10, 2026.

Why it matters

This is a standard procedural announcement for an upcoming AGM and does not contain material information that would significantly impact the company's stock price or business operations.

The market read

The announcement is a routine corporate communication regarding the AGM schedule and related procedures, with no specific financial or operational updates that would indicate a positive or negative sentiment.

Global Health Limited (Medanta) announced that its 22nd Annual General Meeting (AGM) will be held on Wednesday, September 16, 2026, at 12 Noon IST. The meeting will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM), in compliance with SEBI regulations and MCA circulars. The Notice of the 22nd AGM and the Annual Report for the Financial Year 2025-26 have been dispatched to shareholders via electronic mode on August 21, 2026. Copies are also available on the company's website and the stock exchanges.

Shareholders whose names are recorded as of Thursday, September 10, 2026, will be eligible to participate. The company is providing an e-voting facility through NSDL, with remote e-voting commencing on Saturday, September 12, 2026, at 9:00 AM IST and concluding on Tuesday, September 15, 2026, at 5:00 PM IST. Members who have already voted remotely can attend the AGM but cannot vote again. Those who haven't can vote during the AGM.

Details regarding participation and e-voting procedures are provided in the AGM Notice. The company also updated that members holding physical shares need to submit KYC documents to the RTA, M/S KFIN Technologies Limited, for services and dividend credit. Shareholders holding shares in demat form should update their details with their respective DPs. Queries can be directed to compliance@medanta.org or through NSDL's contact channels.

Filing to action

What to do with a filing like this

Global Health Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Global Health Limited. Read the original for the full detail.

View original filing